March 24, 2022Open Access

CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

With NGS and CRISPR/Cas9, the goal is no longer to match the treatment for the diagnosed tumor but rather to build a treatment method that fits the tumor exactly. Hence, in this review, we have discussed the potential role of CRISPR/Cas9 and NGS in advancing personalized medicine.

Bookmark

View Full Paper

Cite This Study

Selvakumar et al. (Thu,) studied this question.

synapsesocial.com/papers/69de9dc1210a0977fce94f02 https://doi.org/https://doi.org/10.1186/s12943-022-01565-1

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Next-generation sequencing in thyroid cancer2016 · 78 citations
2Perspective on Precision Medicine in Oncology2017 · 25 citations
3Implications of CRISPR/Cas9 system in Hypertension and its related diseases2020 · 6 citations
4Next-generation sequencing in liquid biopsy: cancer screening and early detection2019 · 573 citations
5A dual-deaminase CRISPR base editor enables concurrent adenine and cytosine editing2020 · 242 citations

Bookmark

View Full Paper